HomeELTP • OTCMKTS
add
Elite Pharmaceuticals, Inc. Common Stock
Previous close
$0.41
Day range
$0.41 - $0.43
Year range
$0.12 - $0.75
Market cap
450.22M USD
Avg Volume
862.63K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 14.36M | -7.56% |
Operating expense | 5.02M | 43.13% |
Net income | -10.89M | -1,641.99% |
Net profit margin | -75.83 | -1,766.59% |
Earnings per share | — | — |
EBITDA | 1.53M | -60.52% |
Effective tax rate | -2.25% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.29M | 42.59% |
Total assets | 90.76M | 21.50% |
Total liabilities | 54.31M | 92.03% |
Total equity | 36.45M | — |
Shares outstanding | 1.07B | — |
Price to book | 13.72 | — |
Return on assets | 3.07% | — |
Return on capital | 5.16% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -10.89M | -1,641.99% |
Cash from operations | -1.06M | 55.47% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -193.10K | -413.92% |
Net change in cash | -1.26M | 55.63% |
Free cash flow | -1.05M | 66.56% |
About
Founded
1997
Headquarters
Website
Employees
64
